A detailed history of Greenwood Capital Associates LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Greenwood Capital Associates LLC holds 20,524 shares of VRTX stock, worth $8.38 Million. This represents 1.27% of its overall portfolio holdings.

Number of Shares
20,524
Previous 21,193 3.16%
Holding current value
$8.38 Million
Previous $9.93 Million 3.91%
% of portfolio
1.27%
Previous 1.33%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$460.0 - $505.78 $307,740 - $338,366
-669 Reduced 3.16%
20,524 $9.55 Million
Q2 2024

Aug 08, 2024

BUY
$392.81 - $485.53 $415,592 - $513,690
1,058 Added 5.25%
21,193 $9.93 Million
Q1 2024

May 01, 2024

SELL
$407.69 - $446.08 $2.12 Million - $2.32 Million
-5,210 Reduced 20.56%
20,135 $8.42 Million
Q4 2023

Mar 05, 2024

BUY
$343.0 - $410.68 $883,568 - $1.06 Million
2,576 Added 11.31%
25,345 $10.3 Million
Q3 2023

Oct 18, 2023

SELL
$338.18 - $362.46 $1.84 Million - $1.97 Million
-5,429 Reduced 19.25%
22,769 $7.92 Million
Q2 2023

Aug 07, 2023

SELL
$314.42 - $351.91 $99,042 - $110,851
-315 Reduced 1.1%
28,198 $9.92 Million
Q1 2023

May 12, 2023

BUY
$283.23 - $323.1 $104,795 - $119,547
370 Added 1.31%
28,513 $8.98 Million
Q4 2022

Jan 26, 2023

SELL
$285.76 - $321.48 $650,389 - $731,688
-2,276 Reduced 7.48%
28,143 $0
Q3 2022

Nov 10, 2022

SELL
$273.83 - $305.53 $211,944 - $236,480
-774 Reduced 2.48%
30,419 $8.81 Million
Q2 2022

Aug 10, 2022

BUY
$234.96 - $292.55 $7.27 Million - $9.05 Million
30,938 Added 12132.55%
31,193 $8.79 Million
Q1 2022

May 10, 2022

SELL
$221.42 - $260.97 $12.2 Million - $14.4 Million
-55,061 Reduced 99.54%
255 $67,000
Q4 2021

Feb 03, 2022

SELL
$177.01 - $223.45 $41,066 - $51,840
-232 Reduced 0.42%
55,316 $12.1 Million
Q3 2021

Oct 27, 2021

BUY
$181.39 - $202.99 $1.13 Million - $1.26 Million
6,219 Added 12.61%
55,548 $10.1 Million
Q2 2021

Aug 16, 2021

BUY
$187.49 - $221.1 $5.1 Million - $6.01 Million
27,202 Added 122.94%
49,329 $9.95 Million
Q1 2021

May 14, 2021

BUY
$207.02 - $241.31 $475,731 - $554,530
2,298 Added 11.59%
22,127 $4.76 Million
Q4 2020

Feb 09, 2021

BUY
$207.01 - $276.09 $4.1 Million - $5.47 Million
19,829 New
19,829 $4.69 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Greenwood Capital Associates LLC Portfolio

Follow Greenwood Capital Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenwood Capital Associates LLC with notifications on news.